Short Interest in Aytu BioPharma, Inc. (NASDAQ:AYTU) Grows By 8.3%

Aytu BioPharma, Inc. (NASDAQ:AYTU) was the recipient of a significant increase in short interest during the month of January. As of January 15th, there was short interest totalling 137,300 shares, an increase of 8.3% from the December 31st total of 126,800 shares. Based on an average daily trading volume, of 33,600 shares, the days-to-cover ratio is currently 4.1 days. Currently, 2.3% of the company’s stock are sold short.

Aytu BioPharma Stock Performance

NASDAQ:AYTU traded down $0.03 during trading hours on Monday, reaching $1.64. 10,031 shares of the stock were exchanged, compared to its average volume of 21,463. The stock has a market capitalization of $10.09 million, a P/E ratio of -1.33 and a beta of -1.45. The firm has a 50 day simple moving average of $1.62 and a 200-day simple moving average of $2.07. The company has a quick ratio of 0.80, a current ratio of 0.99 and a debt-to-equity ratio of 0.35. Aytu BioPharma has a 52 week low of $1.30 and a 52 week high of $3.45.

Hedge Funds Weigh In On Aytu BioPharma

An institutional investor recently raised its position in Aytu BioPharma stock. Dimensional Fund Advisors LP lifted its holdings in Aytu BioPharma, Inc. (NASDAQ:AYTU) by 54.5% during the second quarter, according to the company in its most recent filing with the SEC. The fund owned 23,551 shares of the company’s stock after buying an additional 8,311 shares during the quarter. Dimensional Fund Advisors LP owned approximately 0.39% of Aytu BioPharma worth $69,000 as of its most recent filing with the SEC. 33.49% of the stock is owned by institutional investors and hedge funds.

Aytu BioPharma Company Profile

Aytu Biopharma, Inc is a specialty pharmaceutical company, which engages in identifying, acquiring, and commercializing novel products. It operates through the Rx and Consumer Health segments. The RX segment consists of various prescription pharmaceutical products sold through third parties. The Consumer Health segment includes various consumer health products sold directly to consumers.